Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]
Erasca, Inc. (ERAS)
Company Research
Source: Yahoo! Finance
Erasca notched another three-year high anew on Thursday, as investor sentiment continued to be fueled by four investment firms' bullish outlooks for its stock, with the company earning a price target upgrade of as much as 267 percent. At intra-day trading, Erasca Inc. (NASDAQ:ERAS) touched a new record high of $9.72 before trimming a few cents to finish the session just up by 15.04 percent at $9.56 apiece. The rally followed a flurry of positive coverage from Clear Street, HC Wainwright, Piper Sandler, and Stifel, with the said analysts issuing “buy” and “overweight” ratings for the stock. Among the four, Clear Street became the most bullish, raising its price target by 267 percent to $11 from $3 previously, while maintaining a “buy” recommendation. Meanwhile, HC Wainwright also gave a price target of $11 versus $6 previously, with a “buy” recommendation, following Erasca Inc.'s (NASDAQ:ERAS) positive preliminary results from the clinical study of its pan-RAS molecular glue d
Show less
Read more
Impact Snapshot
Event Time:
ERAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ERAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ERAS alerts
High impacting Erasca, Inc. news events
Weekly update
A roundup of the hottest topics
ERAS
News
- Tango rises after Q4 results, clinical pact with Erasca [Seeking Alpha]Seeking Alpha
- Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]Yahoo! Finance
- Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat [Yahoo! Finance]Yahoo! Finance
- Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and VopimetostatGlobeNewswire
- Assessing Erasca (ERAS) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
ERAS
Earnings
- 11/12/25 - In-Line
ERAS
Sec Filings
- 3/6/26 - Form 4
- 3/4/26 - Form 144
- 2/17/26 - Form 144
- ERAS's page on the SEC website